Contralateral Acupuncture in the Treatment of Chronic Shoulder Pain

Sponsor
Peking University (Other)
Overall Status
Completed
CT.gov ID
NCT01733914
Collaborator
University of Maryland (Other)
80
1
2
23
3.5

Study Details

Study Description

Brief Summary

According to traditional Chinese medical theories, a variety of acupuncture formulas can treat diseases such as pain. For example, stimulating acupoints either local or distal to the pain site has been proposed under some conditions. We hypothesize that stimulating acupoints contralateral to the pain site can successfully treat chronic shoulder pain.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Acupuncture
  • Other: Control
Phase 2

Study Design

Study Type:
Interventional
Actual Enrollment :
80 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Phase II Study of Contralateral Acupuncture in the Treatment of Chronic Shoulder Pain
Study Start Date :
Sep 1, 2011
Actual Primary Completion Date :
Apr 1, 2013
Actual Study Completion Date :
Aug 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Experimental: Acupuncture

Experimental group

Procedure: Acupuncture
Acupuncture in the following acupoints on the contralateral side of pain site: Jiantong, Zhongzhu, Houxi, and Quchi. The patient will receive 5 treatments (each lasts 30 min) per week for four weeks.

Sham Comparator: Waiting list

Control group

Other: Control
Patients in the waiting list group received conventional orthopaedic therapy including physical exercise, heat or cold therapy. 50 mg diclofenac daily could be taken when the patient suffered from the pain. Injections or cortisone applications of any kind were not allowed.

Outcome Measures

Primary Outcome Measures

  1. Visual analogue scale (VAS) [before and 2, 4, 8 and 16 weeks after treatment start]

    Pain assessment

Secondary Outcome Measures

  1. The MOS item short from health survey (SF-36) [before and 8 and 16 weeks after treatment start]

    Quality of life assessment

  2. Constant-Murley score [before and 2, 4, 8 and 16 weeks after treatment start]

    shoulder motion score

  3. DASH score [before and 2, 4, 8 and 16 weeks after treatment start]

Eligibility Criteria

Criteria

Ages Eligible for Study:
25 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Uni-lateral shoulder pain for 6 weeks to 2 years

  • VAS score ≤ 50

  • 25-65 years of age

  • Positive Neer's or Hawkins' signs

  • Accept the informed consent

Exclusion Criteria:
  • Shoulder pain of neurological origins

  • Shoulder pain of neck origins

  • Systematic arthritis

  • Wrist problems

  • Previous shoulder, arm, neck or chest fractures or surgeries

  • Mental diseases

  • Pregnancy

  • Inability to work for more than 3 months before treatment

  • Diabetes

  • Coagulative dysfunction

  • Corticosterone or physicotherapy experience on the affected shoulder in the last 6 months

  • Failure to accept the informed consent

Contacts and Locations

Locations

Site City State Country Postal Code
1 Province Hospital of Integrative Chinese and Western Medicine, Sichuan Chengdu Sichuan China 100191

Sponsors and Collaborators

  • Peking University
  • University of Maryland

Investigators

  • Principal Investigator: Ming Yi, PhD, Peking University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ming Yi, PhD, principle investigator, Dr, Peking University
ClinicalTrials.gov Identifier:
NCT01733914
Other Study ID Numbers:
  • 2007CB512501
First Posted:
Nov 27, 2012
Last Update Posted:
Apr 14, 2015
Last Verified:
May 1, 2014
Keywords provided by Ming Yi, PhD, principle investigator, Dr, Peking University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 14, 2015